Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT00724360 · TERMINATED
Trial details
- NCT number
- NCT00724360
- Sponsor
- Nantes University Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2011-07-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.